Duojiao Wu
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Cancer Genomics and Diagnostics 5
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 4
- Immunology top 5%
- Immune Cell Function and Interaction 11
- Immune cells in cancer 11
- Biochemistry top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 12
- Transplantation top 10%
-
- Single-cell and spatial transcriptomics 7
- Co-authors
- Xiangdong WangGeng ChenYunjin LiYunfeng ChengDavid E. SaninFangming LiuQiongyu ChenJing Qiu
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)SHILAP Revista de lepidopterología (8 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Duojiao Wu
69 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 406
- Immunology 561
- Biochemistry 112
- Oncology 405
- Transplantation 35
Countries citing papers authored by Duojiao Wu
This map shows the geographic impact of Duojiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duojiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duojiao Wu more than expected).
Fields of papers citing papers by Duojiao Wu
This network shows the impact of papers produced by Duojiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duojiao Wu. The network helps show where Duojiao Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Duojiao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 23 | |
| 3 | 2024 | 1 | |
| 4 | CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factorbreakdown → | 2023 | 209 |
| 5 | 2023 | 8 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 9 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 7 | |
| 10 | 2019 | 19 | |
| 11 | 2017 | 22 | |
| 12 | 2016 | 254 | |
| 13 | 2016 | 10 | |
| 14 | 2016 | 12 | |
| 15 | 2014 | 10 | |
| 16 | 2014 | 25 | |
| 17 | 2012 | 73 | |
| 18 | 2011 | 20 | |
| 19 | 2011 | 11 | |
| 20 | [Effect of shexiang baoxin pill in alleviating myocardial fibrosis in spontaneous hypertensive rats]. | 2005 | 11 |
About Duojiao Wu
Duojiao Wu is a scholar working on Immunology, Cancer Research and Transplantation, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (11 papers), Immune cells in cancer (11 papers), Single-cell and spatial transcriptomics (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (406 citations), Immunology (561 citations) and Biochemistry (112 citations). Duojiao Wu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiangdong Wang, Xiangdong Wang, Geng Chen, Yunjin Li, Yunfeng Cheng, David E. Sanin, Fangming Liu, Qiongyu Chen, Jing Qiu and Annette Patterson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.